Piper Sandler Companies (PIPR) is in focus after hosting its Virtual Ophthalmology Day in Miami on July 9, 2026. The event highlighted the firm’s healthcare focus alongside its role in capital markets.

Recent moves in Piper Sandler Companies’ stock have been mixed, with a 1 day share price return of 3.75% and 7 day share price return of 9.68%, but a 90 day share price return that is down 12.46%. The 5 year total shareholder return of 198.58% points to strong longer term compounding even as shorter term momentum has cooled.

If Piper Sandler’s sector views have you thinking about where else capital could go next, it may be worth scanning 18 top founder-led companies

After a strong multi year run and a recent pullback that leaves Piper Sandler Companies trading below some analyst targets, the key issue now is whether most of the easy gains are behind the stock or if meaningful upside is still ahead.

Most Popular Narrative: 11.8% Undervalued

Compared with the last close at $77.75, the most followed narrative pegs Piper Sandler Companies' fair value at $88.13, setting up a modest undervaluation story built on specific business drivers.

Growth in private credit and sponsor activity is expanding the opportunity set for debt capital markets advisory, private capital advisory and restructuring work. This can affect advisory revenues and support operating leverage as more of the fee pool shifts to these higher value services.

Want to see how this advisory heavy mix underpins that fair value gap? The core of the narrative is faster earnings, wider margins, and a lower future earnings multiple than the broader capital markets peer group. Curious which assumptions really carry the model and how sensitive the outcome is to small changes in growth and profitability?

Result: Fair Value of $88.13 (UNDERVALUED)

However, investors still need to weigh the risk that weaker equity markets or softer bank M&A and balance sheet activity could challenge the narrative for Piper Sandler.

Another View on Piper Sandler Companies' Valuation

The fair value narrative for Piper Sandler Companies leans on earnings, margins and a target P/E that suggest the stock is 11.8% undervalued. Yet on current numbers, PIPR trades on a 19.6x P/E versus a fair ratio of 15.9x, which implies a richer price than that model points to.

At the same time, that 19.6x P/E is well below the US Capital Markets industry average of 40.3x and the peer average of 22.8x. This comparison paints PIPR as cheaper than many direct competitors. The question for investors is whether the market eventually moves closer to the fair ratio or leans more on the relative discount to peers.

To see how the current P/E stacks up against sector benchmarks in more detail, take a look at the valuation breakdown in See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed signals around Piper Sandler Companies' valuation and outlook, do not wait for consensus to form; instead, weigh the trade off between potential upside and downside by reviewing the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Piper Sandler Companies?

If you stop with just Piper Sandler Companies, you risk missing other compelling setups, so put a few more ideas on your radar using the Simply Wall Street Screener.

• Pinpoint potential upside in quality companies trading at appealing valuations by scanning 47 high quality undervalued stocks.
• Target resilience and capital preservation first by reviewing 78 resilient stocks with low risk scores that aim to keep volatility in check.
• Spot strong businesses that the market may be overlooking by working through screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.